Futura Medical (LON:FUM) Sets New 52-Week Low – Here’s Why

Futura Medical plc (LON:FUM) shares reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as GBX 21.50 ($0.27) and last traded at GBX 33.30 ($0.42), with a volume of 10440612 shares changing hands. The stock had previously closed at GBX 33.68 ($0.42).

Futura Medical Stock Down 1.1 %

The firm has a market cap of £100.70 million, a price-to-earnings ratio of -3,367.50 and a beta of 1.25. The company’s 50-day moving average price is GBX 34.90 and its 200-day moving average price is GBX 35.95.

Insider Buying and Selling

In other Futura Medical news, insider James Henry Barder sold 250,000 shares of Futura Medical stock in a transaction on Friday, September 13th. The shares were sold at an average price of GBX 41 ($0.52), for a total transaction of £102,500 ($128,849.78). 32.14% of the stock is currently owned by insiders.

Futura Medical Company Profile

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.